|
KMID : 1009020170150030282
|
|
Clinical Psychopharmacology and Neuroscience
2017 Volume.15 No. 3 p.282 ~ p.284
|
|
|
Galactorrhea Probably Related with Switching from Osmotic-release Oral System Methylphenidate (MPH) to Modified-release MPH: An Adolescent Case
|
|
Ekinci Ozalp
Gunes Serkan
Ekinci Nuran
|
|
|
Abstract
|
|
|
|
Galactorrhea, as an adverse effect of psychotropic medications, usually develops due to high dose of antipsychotics. Selective serotonin reuptake inhibitors (SSRIs) have also been reported to be related to galactorrhea. To the best of our knowledge, no previous study reported galactorrhea with methylphenidate (MPH) use. Hereby, we report a case of an adolescent girl who developed galactorrhea after increasing his modifed-release oral MPH to 50 mg/day while under treatment of sertraline and very low dose haloperidol.
|
|
|
KEYWORD
|
|
|
Galactorrhea, Methylphenidate, Selective serotonin reuptake inhibitors, Adolescent
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|